…l, authorization § 170.315(d)(1) Remove Effective date of final rule. Auditable events and tamper-resistance § 170.315(d)(2) Remove Effective date of final rule. Audit report(s) § 170.315(d)(3) Remove Effective date of final rule. Amendments § 170.315(d)(4) Remove Effective date …

…nition B. Exceptions 1. Infeasibility a. Infeasibility Exception—Uncontrollable Events Condition b. Third Party Seeking Modification Use c. Manner Exception Exhausted 2. Manner Exception—TEFCA Reasonable and Necessary Activities a. Background b. TEFCA Condition for the “Manner” E…

… highly skilled in evaluating patients and managing clinical issues and adverse events that commonly arise during the procedure, particularly in patients with comorbid anemia, renal failure, cardiovascular disease, serum protein abnormalities or other risk factors. [ 24 ] Their k…

… peripheral artery disease, a condition which is very different than thrombotic events. The commenter reported that percutaneous ultrasonic fragmentation procedures using the EKOS TM device typically involve leaving the EKOS TM device in the body for multiple hours and in many ca…

… peripheral artery disease, a condition which is very different than thrombotic events. The commenter reported that percutaneous ultrasonic fragmentation procedures using the EKOS TM device typically involve leaving the EKOS TM device in the body for multiple hours and in many ca…

…G data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; review and interpretation with report by a physician or other qualified health care professional ), we disagreed with the…

…Additional Supply of Medication (Resupply) xii. Communicate Drug Administration Events (DrugAdministration) xiii. Request and Respond to Transfer One or More Prescriptions Between Pharmacies (RxTransferRequest, RxTransferResponse, RxTransferConfirm) xiv. Recertify the Continued A…

… instead interquartile ranges ( 90 FR 18099 ). The applicant summarized adverse events reported in Cauchy et al. (2011) and Crooks et al. (2022), as well as a multicenter retrospective cohort study and the AURLUMYN TM prescribing information. The applicant also referenced the NDA…

…(such as under the Inspector General Act of 1978). Nothing in this final rule prevents payers from sharing the requested data via these APIs, if technologically feasible, for appropriate purposes permitted by law. We encourage using these standards-based APIs for purposes beyond …

…in FY 2019 (Figure 5). printed page 19716) Analysis of Part D prescription drug events (PDEs) data suggests that the current use of prior authorization (PA) by Part D sponsors has reduced Part D program payments for drugs in four targeted categories (analgesics, anti-nauseants, a…

…ology (IT) Certification Program” final rule (ONC Cures Act final rule) ( 85 FR 25642 ). This final rule strengthened patients' electronic access (including via a third-party app) to their health information at no cost and added a certification criterion under the ONC Health IT C…

…thentication, access control, and authorization” in § 170.315(d)(1); “auditable events and tamper-resistance” in § 170.315(d)(2); “audit report(s)” in § 170.315(d)(3); “automatic access time-out” in § 170.315(d)(5); “emergency access” in § 170.315(d)(6); “end-user device encrypti…